Nora D. Volkow, Director of the NIDA
1244 7. nóvember, 201740 ára afmælisráðstefna SÁÁ: Addiction Is a Chronic Brain Disease – What We Know Today Nora D. Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Abstract Addiction is a disorder that involves complex interactions between genes, development and the social environment. Studies employing neuroimaging technology paired …Read more »
Jeffrey Goldsmith, Past President of ASAM
1243 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: The complexities of managing people with addictions Jeffrey Goldsmith MD, DLFAPA, DFASAM, past president of ASAM Abstract Addiction health care providers get confused when managing care for addiction. This may stem from care providers using different models of addiction. The referral source is often not using the same model of addiction …Read more »
George Woody, Perelman School of Medicine
1236 7. nóvember, 201740 ára afmælisráðstefna SÁÁ: International research on addiction treatment George Woody MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania Abstract The HIV epidemic generated a high level of interest in addiction research, particularly treatment research, due to it association with injecting drug use, and drug use and unprotected sex. The result …Read more »
Arndís Sue Ching Löve, PhD student MS Pharm
1216 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Estimation of community drug abuse in the Reykjavík metropolitan area by wastewater analysis Arndís Sue Ching Löve, PhD student MS Pharm Abstract Introduction: Drug abuse has been a matter of concern worldwide due to the risks these substances pose to human health, and their connection to crime. Sewage epidemiology is a methodology used …Read more »
Nora D. Volkow, Director of the NIDA
1209 31. október, 201740 ára afmælisráðstefna SÁÁ Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the …Read more »
Kári Stefánsson, CEO Decode Genetics
1200 24. október, 2017Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors of deCODE genetics in December 1999. From 1993 until April 1997, Dr. Stefánsson was a professor of Neurology, Neuropathology and Neuroscience …Read more »
Nora D. Volkow, Director of NIDA
1198 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Cannabis and society – can science guide public policies? Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. …Read more »
Þórólfur Guðnason, Chief Epidemiologist
1179 8. nóvember, 2017Seminar: Viral infections and addiction, HIV and Hepatitis C Chair – Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health
Gregory Bunt, MD, FISAM
1174 8. nóvember, 201740 ára afmælisráðstefna SÁÁ: Medicinal Marijuana, Policy and Physician Gregory Bunt, MD FISAM, President, International Society of Addiction Medicine Diplomate, American Board of Psychiatry and Neurology, Clinical Assistant Professor of Psychiatry, NYU School of Medicine, New York, NY Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry …Read more »
Efni
- 2. okt. – Fjögur málþing (17)
- Fíkn og afbrot (4)
- Fíkn og konur (5)
- Fíkn og pólitík (4)
- Fíkn og stofnanir (4)
- 3. okt. – Fyrirlestrar (15)
- Cannabis (4)
- 4. okt. – Fyrirlestrar (16)
- Viðtöl (11)